PMID: 11321389Apr 26, 2001Paper

Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: preliminary results

Journal of Pediatric Gastroenterology and Nutrition
S FacchiniA Ventura

Abstract

Several proinflammatory cytokines are involved in the pathogenesis of inflammatory bowel diseases. A significant role has been given to tumor necrosis factor alpha (TNF-alpha) as a guide proinflammatory cytokine. Thalidomide selectively reduces TNF-alpha production by inflammatory cells. The aim of the study was to assess the efficacy of thalidomide to induce and maintain remission in refractory Crohn disease. The decision to administer thalidomide was made on the basis of patient intolerance or resistance to conventional medical treatment or as the last medical resort before surgical intervention. Only 5 of 96 patients with inflammatory bowel disease satisfied these criteria. All five patients had Crohn disease (male: mean age, 17 years). Thalidomide was administered at night at a dose of 1.5-2 mg/kg/day. The Pediatric Crohn Disease Activity Index, modified Harvey-Bradshaw scores, and steroids reduction were used to assess clinical response. Disease activity decreased consistently in four patients with a reduction of mean Pediatric Crohn Disease Activity Index from 36,9 to 2,5 and the mean Harvey-Bradshaw from 8.5 to 0.75 after 3 months of treatment. Steroid treatment (mean dose, 35 mg/day before treatment) was tapered and the...Continue Reading

References

Mar 24, 1979·British Medical Journal·M F WatersJ E Lennard-Jones
May 1, 1991·Journal of Pediatric Gastroenterology and Nutrition·J S HyamsJ T Boyle
Jun 1, 1993·The Journal of Experimental Medicine·A L MoreiraG Kaplan
Dec 1, 1996·Clinical Immunology and Immunopathology·J D KlausnerG Kaplan
Apr 1, 1997·Gut·S J Van Deventer
Nov 26, 1997·Lancet·A R Wettstein, A P Meagher
Feb 5, 1999·Journal of Pediatric Gastroenterology and Nutrition·T A WeinsteinJ Levine
Mar 24, 1999·Arthritis and Rheumatism·M BrebanM Dougados

❮ Previous
Next ❯

Citations

Sep 7, 2004·European Journal of Clinical Pharmacology·Federico MarchettiAlessandro Ventura
Jun 6, 2007·Current Treatment Options in Gastroenterology·Mark T Osterman, Gary R Lichtenstein
Jan 26, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·B Combe
Dec 13, 2002·The New England Journal of Medicine·Jaime García de TenaMelchor Alvarez-Mon
May 10, 2003·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Anne HegartyStephen Porter
Oct 13, 2006·Current Opinion in Gastroenterology·Jeffry A Katz
Aug 13, 2002·Journal of Clinical Gastroenterology·Sunanda KaneEli Ehrenpreis
Sep 26, 2003·Journal of Pediatric Gastroenterology and Nutrition·M AhmedH R Jenkins
Mar 27, 2003·Inflammatory Bowel Diseases·Johanna C EscherRichard J Grand
Apr 13, 2002·Drugs & Aging·Shufeng ZhouJames W Paxton
Dec 29, 2007·Paediatric Drugs·Shehzad A Saeed, Wallace V Crandall
May 3, 2005·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Tomoyuki KabukiTsutomu Oh-Ishi
May 17, 2003·Clinical Therapeutics·S James Matthews, Christopher McCoy
Apr 23, 2004·Expert Opinion on Investigational Drugs·Radhika Srinivasan, Gary R Lichtenstein
Feb 28, 2002·Expert Opinion on Investigational Drugs·Ece A MutluAli Keshavarzian
Sep 4, 2010·Pharmacology & Therapeutics·Ian A ClarkBryce Vissel
Sep 18, 2012·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Xin JinQianming Chen
Feb 8, 2005·Neuromuscular Disorders : NMD·Fiona J FlemingMonique M Ryan
Jul 29, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William A Faubion, Athos Bousvaros
Apr 11, 2015·Alimentary Pharmacology & Therapeutics·C YangW El-Matary
Oct 13, 2007·Expert Opinion on Pharmacotherapy·A R Bremner, R M Beattie
Apr 20, 2005·Neonatal Network : NN·Davita Hammer
Dec 2, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·R CaprilliM Zippi
Oct 30, 2016·The Journal of Pediatrics·Wendy K M LiewPeter B Kang
Mar 14, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Marzia LazzeriniAlessandro Ventura
May 28, 2004·Journal of Child Neurology·Johan F SchoemanGilla Kaplan
Dec 7, 2017·World Journal of Gastroenterology : WJG·Lin WangYing Huang
Jul 30, 2016·Medicine·Matteo BramuzzoMarzia Lazzerini
Jun 18, 2011·Journal of Pediatric Gastroenterology and Nutrition·Lina M FelipezBarbara S Kirschner
Jan 19, 2010·Journal of Pediatric Gastroenterology and Nutrition·D C WilsonS H Murch
May 22, 2008·Journal of Pediatric Gastroenterology and Nutrition·Kristiina JarviJoe I Curry
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Ramesh Srinivasan, Anthony K Akobeng
Aug 4, 2020·Journal of Clinical Pharmacy and Therapeutics·Tingting QiuSuodi Zhai
Apr 14, 2015·Expert Review of Clinical Immunology·Antonella DiamantiGiuliano Torre
Nov 25, 2016·Experimental and Therapeutic Medicine·Ying Zhou, Ying Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.